JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Primus, R. J.
Right arrow Articles by Gallager, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Primus, R. J.
Right arrow Articles by Gallager, D. W.

Vol. 282, Issue 2, 1020-1027, 1997

II. Localization and Characterization of Dopamine D4 Binding Sites in Rat and Human Brain by Use of the Novel, D4 Receptor-Selective Ligand [3H]NGD 94-1

Renee J. Primus, Andrew Thurkauf, Jing Xu, Eileen Yevich, Sean Mcinerney, Kenneth Shaw, John F. Tallman and Dorothy W. Gallager

Neurogen Corporation, Branford, Connecticut

The dopamine D4 selective ligand, [3H]NGD 94-1, was used in these studies to characterize binding sites in rat and human brain tissue by membrane binding and autoradiography techniques. Autoradiographic analysis of rat brain showed that specific [3H]NGD 94-1 binding was greatest in entorhinal cortex, lateral septal nucleus, hippocampus and the medial preoptic area of the hypothalamus. This nonstriatal distribution of [3H]NGD 94-1 binding was distinct from the autoradiographic distribution of dopamine D2 and D3 receptor subtypes. In homogenate preparations from rat brain regions, [3H]NGD 94-1 binding sites were low in density (<30.0 fmol/mg protein). The low density of D4 binding sites was corroborated by autoradiographic comparisons in which binding density for D4 receptors as measured by [3H]NGD 94-1 was only 1/7 of D2 and 1/5 of D3 receptor densities, despite corrections for differing radioligand binding characteristics. Pharmacological evaluation showed high affinity at rat [3H]NGD 94-1 binding sites for compounds with known D4 receptor affinity and little displacement by compounds with affinity for dopamine D1/D2/D3 receptor subtypes. Specific, high-affinity [3H]NGD 94-1 binding was also present in several human brain regions, including hippocampus, hypothalamus, dorsal medial thalamus, entorhinal cortex, prefrontal cortex and lateral septal nucleus. High-affinity [3H]NGD 94-1 binding was not present in any human striatal region examined. The pharmacological profile of [3H]NGD 94-1 binding sites in human brain was consistent with that previously demonstrated for cloned human D4 receptors expressed in mammalian cells. These findings suggest that specific, high-affinity [3H]NGD 94-1 binding exists in rat and human brain and that these sites reflect populations of dopamine D4 receptors with a distribution unique among dopamine receptor subtypes.

Copyright © by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Arch Gen PsychiatryHome page
C. G. DeYoung, J. B. Peterson, J. R. Seguin, J. M. Mejia, R. O. Pihl, J. H. Beitchman, U. Jain, R. E. Tremblay, J. L. Kennedy, and R. M. Palmour
The Dopamine D4 Receptor Gene and Moderation of the Association Between Externalizing Behavior and IQ
Arch Gen Psychiatry, December 1, 2006; 63(12): 1410 - 1416.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
Y. Asaumi, H. Hasuo, and T. Akasu
Dopamine Presynaptically Depresses Fast Inhibitory Synaptic Transmission via D4 Receptor-Protein Kinase A Pathway in the Rat Dorsolateral Septal Nucleus
J Neurophysiol, August 1, 2006; 96(2): 591 - 601.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. D. Brioni, R. B. Moreland, M. Cowart, G. C. Hsieh, A. O. Stewart, P. Hedlund, D. L. Donnelly-Roberts, M. Nakane, J. J. Lynch III, T. Kolasa, et al.
Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats
PNAS, April 27, 2004; 101(17): 6758 - 6763.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Sato, M. M. Meguid, S. O. Fetissov, C. Chen, and L. Zhang
Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1907 - R1916.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. J. Millan, A. Newman-Tancredi, M. Brocco, A. Gobert, F. Lejeune, V. Audinot, J.-M. Rivet, R. Schreiber, A. Dekeyne, M. Spedding, et al.
S 18126 ({2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl}), a Potent, Selective and Competitive Antagonist at Dopamine D4 Receptors: An In Vitro and In Vivo Comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2,3b]pyridine) and Raclopride
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 167 - 186.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. J. Millan, R. Schreiber, A. Dekeyne, J.-M. Rivet, K. Bervoets, M. Mavridis, C. Sebban, S. Maurel-Remy, A. Newman-Tancredi, M. Spedding, et al.
S 16924 ((R)-2-{1-[2-(2,3-Dihydro-Benzo[1,4] Dioxin-5-Yloxy)-Ethyl]-Pyrrolidin-3yl}-1-(4-Fluoro-Phenyl)-Ethanone), a Novel, Potential Antipsychotic with Marked Serotonin (5-HT)1A Agonist Properties: II. Functional Profile in Comparison to Clozapine and Haloperidol
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1356 - 1373.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.